 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 61 - 70 of 2187:
Abilify for autism-linked irritability approved by FDA
The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 t...
Abiomed gets FDA OK to test new circulatory support system
Abiomed Inc. has received conditional approval from the U.S. Food and Drug Administration to begin a clinical trial in the United States for the Impel...
Accelerating Disaster Recovery into Business Continuity
The global enterprise has a voracious appetite for data, and little patience for downtime. According to a recent Forrester report, 82 percent of large...
Accentia starts FDA approval process for MS treatment
Accentia Biopharmaceuticals Inc. filed a preliminary Investigational New Drug application for the U.S. Food and Drug Administration for Revimmune, for...
Aclidinium tests commenced by Almirall to get FDA's Approval
Almirall a drug maker from Spain said that it had begun a programme to comply with U.S. and EU authorities' recommendations regarding phase III trials...
Acorda's MS Drug Won't be Reviewed by FDA
Acorda Therapeutics disclosed that U.S. regulators have refused to review the company's multiple sclerosis drug for approval.More on ACOR Top Takes Fr...
Actions Taken by FDA to Stop the Marketing of Unapproved Prescription Narcotic Drugs
Around nine companies have been given warning by the Food and Drug Administration to stop manufacturing 14 unapproved narcotic drugs that are marketed...
Activists decry paucity of US FDA device checks
The Project on Government Oversight (POGO) called on Wednesday for an investigation into the U.S. Food and Drug Administration's early laboratory insp...
Acusphere cuts jobs while waiting for FDA decision
Pharmaceutical company Acusphere Inc. said Monday it has cut it work force by 24 people, or 25 percent, and senior managers will take salary cuts of 1...
Adolor Under the FDA's Spotlight
Drugmaker Adolor got a bit of surprising good news from the FDA on Friday, only a few weeks ahead of an upcoming FDA decision on whether to approve th... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |